SCHEMBL20711225

SCHEMBL20711225

Nc1cc(C(F)(F)F)ccc1C(=O)NS(=O)(=O)NC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20711346 0.91 TRPM2 (0.58) —
SCHEMBL20711280 0.89 TRPM2 (0.57) —
SCHEMBL20711309 0.88 TRPM2 (0.66) —
SCHEMBL20711195 0.87 TRPM2 (0.71) —
SCHEMBL20711220 0.87 TRPM2 (0.61) —
SCHEMBL20711348 0.84 TRPM2 (0.57) —
SCHEMBL20711315 0.84 TRPM2 (0.77) —
SCHEMBL20711226 0.83 DOT1L (0.56) —
SCHEMBL20711284 0.81 TRPM2 (0.56) —
SCHEMBL20711278 0.81 TRPM2 (0.61) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10874686-B2 Anthranilyl-adenosinemonosulfamate analogs and uses thereof MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2020-12-29 — — US disclosed
US-20190038656-A1 ANTHRANILYL-ADENOSINEMONOSULFAMATE ANALOGS AND USES THEREOF Memorial Slooan-Kettering Cancer Center (US) 2019-02-07 — — US disclosed
Send feedback